Neuronetics Shares Fall 14% After Public Offering Announcement
Neuronetics shares fell 14% to $1.73 in premarket trading after the company announced an underwritten public offering it expects to help pay down debt and resolve going-concern risk.
By Kelly CloonanShares of Neuronetics declined after the company announced an underwritten public offering it expects to help it pay down some of its debt and resolve its going concern risk.The stock fell 14% to $1.73 in premarket trading Wednesday. At Tuesday's market close shares were up 46% year…